Buy Avanafil

Avanafil

Avanafil: Generic Medication Overview

Avanafil is an oral medication used to treat erectile dysfunction (ED) in adult men. It belongs to the phosphodiesterase-5 (PDE5) inhibitor class, the same therapeutic category that includes sildenafil and tadalafil. In Hong Kong, avanafil is available by prescription only and is marketed in pill form at strengths of 50 mg, 100 mg, and 200 mg.

How Avanafil Works in the Body

Avanafil selectively inhibits the enzyme phosphodiesterase-5, which normally breaks down cyclic guanosine monophosphate (cG → cGMP) in penile tissue. By blocking PDE5, avanafil allows cGMP to accumulate after sexual stimulation. Elevated cGMP relaxes the smooth muscle of the corpora cavernosa, increasing blood flow into the penis and facilitating an erection.

• Onset: Clinical studies show an onset of erection-facilitating effect within 15 minutes for the 100 mg and 200 mg doses.
• Peak effect: Generally reached within 30-60 minutes.
• Duration: Efficacy can last up to 6 hours, but the medication is taken only as needed before sexual activity.

Because avanafil is highly selective for PDE5, it has a lower affinity for other phosphodiesterases, which may reduce the likelihood of certain side effects compared with less selective agents.

Conditions Treated by Avanafil

Avanafil is approved by the U.S. Food and Drug Administration (FDA) and recognized by Hong Kong health authorities for the treatment of erectile dysfunction in adult males. It is indicated for men who have difficulty achieving or maintaining an erection sufficient for satisfactory sexual performance.

Typical candidates include:

• Men with vascular or neurogenic causes of ED
• Patients who have not responded adequately to lifestyle modifications (e.g., exercise, smoking cessation)
• Individuals seeking a fast-acting oral option for on-demand use

Avanafil is not indicated for women, children, or men with conditions unrelated to erectile function.

Patient Suitability and Contraindications

Who Should Use Avanafil?

• Adults with a confirmed diagnosis of erectile dysfunction
• Patients with stable cardiovascular status who are not taking nitrates
• Individuals who can follow dosing instructions (take the pill 15-30 minutes before sexual activity)

Absolute Contraindications

• Known hypersensitivity to avanafil or any of its excipients
• Concurrent use of organic nitrates (e.g., nitroglycerin, isosorbide dinitrate) in any form
• Use with recreational nitric-oxide donors such as amyl nitrate (“poppers”)

Relative Contraindications

• Severe uncontrolled hypertension (systolic > 180 mm Hg or diastolic > 120 mm Hg)
• Recent history of myocardial infarction, stroke, or unstable angina (within 6 weeks)
• Severe hepatic impairment (Child-Pugh C) or end-stage renal disease (eGFR < 30 ml/min)

Special Populations

• Pregnancy & lactation: Not applicable; avanafil is not indicated for women.
• Elderly: No dose adjustment is required solely based on age, but comorbidities and concurrent medications should be reviewed.

When uncertainty exists about any of these factors, a clinician should assess suitability on a case-by-case basis.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Headache (most frequently reported)
• Flushing or warmth in the face
• Nasal congestion or runny nose
• Dizziness

These effects are usually mild, transient, and resolve without medical intervention. If they persist or become bothersome, patients should discuss alternative dosing or medication options with their healthcare provider.

Serious Adverse Events

• Sudden loss of vision (non-arteritic anterior ischemic optic neuropathy) - rare but requires immediate evaluation.
• Prolonged or painful erections lasting more than 4 hours (priapism) - an emergency that warrants prompt medical attention.

Drug Interactions

• Major: Concomitant use with organic nitrates causes profound hypotension and is contraindicated.
• Moderate: Alpha-blockers (e.g., tamsulosin, doxazosin) may lead to additive blood-pressure lowering effects; dose titration and monitoring are recommended.
• CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) can increase avanafil plasma concentrations, potentially heightening side-effect risk. Dose reduction may be necessary.
• CYP3A4 inducers (e.g., rifampin, carbamazepine) may reduce avanafil effectiveness.

Patients should provide a complete medication list, including over-the-counter drugs, supplements, and herbal products, before initiating avanafil.

Food and Lifestyle Interactions

• Taking avanafil with a high-fat meal may delay onset slightly; however, the effect is modest compared with other PDE5 inhibitors.
• Alcohol in excess can potentiate hypotensive effects and diminish erection quality; moderate consumption is advisable.
• No specific restrictions on driving or operating machinery, but dizziness or hypotension could impair performance; patients should be cautious until they know how they react.

How to Take Avanafil

• Standard dosing: The recommended starting dose for most men is 100 mg taken as a single pill 15 minutes before anticipated sexual activity.
• Dose adjustments: If the 100 mg dose is ineffective and well tolerated, the dose may be increased to 200 mg. Men who experience side effects may reduce the dose to 50 mg.
• Frequency: Avanafil can be taken no more than once per day.
• Administration: Swallow the tablet whole with a glass of water. Do not crush or chew.
• Missed dose: If a sexual encounter does not occur, the pill should be discarded; do not take an additional dose later the same day.
• Overdose: Symptoms may include severe hypotension, dizziness, or prolonged erection. Seek emergency medical care; there is no specific antidote, and supportive measures are used.
• Discontinuation: No tapering is needed. Stopping the medication does not cause withdrawal; however, patients should discuss alternative treatment plans with their physician if needed.

Individual dosing must be personalized by a qualified healthcare professional, taking into account medical history and concomitant medications.

Monitoring and Follow-Up

• Blood pressure: Check prior to initiating therapy and monitor periodically, especially when combined with antihypertensive agents.
• Cardiovascular status: Patients with known heart disease should have a recent evaluation to confirm that sexual activity is safe.
• Adverse effects: Any persistent or severe side effect should prompt a review of therapy.

Routine laboratory testing is not required for avanafil alone unless the patient has hepatic or renal impairment.

Storage and Handling

• Store at room temperature (15 °C-30 °C) away from excess moisture and direct sunlight.
• Keep the medication out of reach of children; use child-proof containers.
• Do not use pills that are discolored, cracked, or past the expiration date printed on the packaging.

Medication-Specific Glossary

Phosphodiesterase-5 (PDE5) Inhibitor

A class of drugs that block the PDE5 enzyme, enhancing cGMP levels to improve penile blood flow.

cGMP (Cyclic Guanosine Monophosphate)

A molecule that mediates smooth-muscle relaxation in the penis, essential for erection development.

Priapism

A prolonged, often painful erection lasting more than four hours; requires urgent medical treatment.

Organic Nitrates

Medications (e.g., nitroglycerin) that release nitric oxide, used for angina; they interact dangerously with PDE5 inhibitors.

Medical Disclaimer

This article provides educational information about avanafil and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.